<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36184826</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1755-5949</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>CNS neuroscience &amp; therapeutics</Title><ISOAbbreviation>CNS Neurosci Ther</ISOAbbreviation></Journal><ArticleTitle>The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases.</ArticleTitle><Pagination><StartPage>37</StartPage><EndPage>59</EndPage><MedlinePgn>37-59</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cns.13985</ELocationID><Abstract><AbstractText>The autophagy-lysosomal pathway (ALP) is involved in the degradation of protein aggregates and damaged organelles. Transcription factor EB (TFEB), a major regulator of ALP, has emerged as a leading factor in addressing neurodegenerative disease pathology, including Alzheimer's disease (AD), Parkinson's disease (PD), PolyQ diseases, and Amyotrophic lateral sclerosis (ALS). In this review, we delineate the regulation of TFEB expression and its functions in ALP. Dysfunctions of TFEB and its role in the pathogenesis of several neurodegenerative diseases are reviewed. We summarize the protective effects and molecular mechanisms of some TFEB-targeted agonists in neurodegenerative diseases. We also offer our perspective on analyzing the pros and cons of these agonists in the treatment of neurodegenerative diseases from the perspective of drug development. More studies on the regulatory mechanisms of TFEB in other biological processes will aid our understanding of the application of TFEB-targeted therapy in neurodegeneration.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. CNS Neuroscience &amp; Therapeutics published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Fengjuan</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-1792-2039</Identifier><AffiliationInfo><Affiliation>School of Mental Health, Jining Medical University, Jining, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shandong Key Laboratory of Behavioral Medicine, School of Mental Health, Jining Medical University, Jining, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Bojie</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Mental Health, Jining Medical University, Jining, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shandong Key Laboratory of Behavioral Medicine, School of Mental Health, Jining Medical University, Jining, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Lingyan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Mental Health, Jining Medical University, Jining, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shandong Key Laboratory of Behavioral Medicine, School of Mental Health, Jining Medical University, Jining, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>CNS Neurosci Ther</MedlineTA><NlmUniqueID>101473265</NlmUniqueID><ISSNLinking>1755-5930</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TFEB agonist</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">autophagy-lysosomal pathway</Keyword><Keyword MajorTopicYN="N">neurodegenerative disease</Keyword><Keyword MajorTopicYN="N">transcription factor EB</Keyword></KeywordList><CoiStatement>The authors declare that there are no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>3</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36184826</ArticleId><ArticleId IdType="pmc">PMC9804079</ArticleId><ArticleId IdType="doi">10.1111/cns.13985</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DiFiglia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997;277(5334):1990&#x2010;1993.</Citation><ArticleIdList><ArticleId IdType="pubmed">9302293</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe DJ. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol. 2004;6(11):1054&#x2010;1061.</Citation><ArticleIdList><ArticleId IdType="pubmed">15516999</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10(Suppl):S10&#x2010;S17.</Citation><ArticleIdList><ArticleId IdType="pubmed">15272267</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross CA, Poirier MA. Opinion: what is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol. 2005;6(11):891&#x2010;898.</Citation><ArticleIdList><ArticleId IdType="pubmed">16167052</ArticleId></ArticleIdList></Reference><Reference><Citation>Shintani T, Klionsky DJ. Autophagy in health and disease: a double&#x2010;edged sword. Science. 2004;306(5698):990&#x2010;995.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1705980</ArticleId><ArticleId IdType="pubmed">15528435</ArticleId></ArticleIdList></Reference><Reference><Citation>Jegga AG, Schneider L, Ouyang X, Zhang J. Systems biology of the autophagy&#x2010;lysosomal pathway. Autophagy. 2011;7(5):477&#x2010;489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3127210</ArticleId><ArticleId IdType="pubmed">21293178</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkbeiner S. The autophagy lysosomal pathway and neurodegeneration. Cold Spring Harb Perspect Biol. 2020;12(3):a033993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6773515</ArticleId><ArticleId IdType="pubmed">30936119</ArticleId></ArticleIdList></Reference><Reference><Citation>Nah J, Yuan J, Jung YK. Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach. Mol Cells. 2015;38(5):381&#x2010;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4443278</ArticleId><ArticleId IdType="pubmed">25896254</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee R, Beal MF, Thomas B. Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. Trends Neurosci. 2010;33(12):541&#x2010;549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2981680</ArticleId><ArticleId IdType="pubmed">20947179</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland B, Yu WH, Corti O, et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2018;17(9):660&#x2010;688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456907</ArticleId><ArticleId IdType="pubmed">30116051</ArticleId></ArticleIdList></Reference><Reference><Citation>Settembre C, Di Malta C, Polito VA, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332(6036):1429&#x2010;1433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3638014</ArticleId><ArticleId IdType="pubmed">21617040</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini&#x2010;Stoica H, Xu Y, Ballabio A, Zheng H. The autophagy&#x2010;lysosomal pathway in neurodegeneration: a TFEB perspective. Trends Neurosci. 2016;39(4):221&#x2010;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4928589</ArticleId><ArticleId IdType="pubmed">26968346</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes CJ, La Spada AR. TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: molecular mechanisms, cellular processes, and emerging therapeutic opportunities. Neurobiol Dis. 2019;122:83&#x2010;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6291370</ArticleId><ArticleId IdType="pubmed">29852219</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai SN, Tiwari N, Singh P, et al. Therapeutic potential of vital transcription factors in Alzheimer's and Parkinson's disease with particular emphasis on transcription factor EB mediated autophagy. Front Neurosci. 2021;15:777347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8712758</ArticleId><ArticleId IdType="pubmed">34970114</ArticleId></ArticleIdList></Reference><Reference><Citation>Tognon E, Kobia F, Busi I, Fumagalli A, De Masi F, Vaccari T. Control of lysosomal biogenesis and notch&#x2010;dependent tissue patterning by components of the TFEB&#x2010;V&#x2010;ATPase axis in Drosophila melanogaster. Autophagy. 2016;12(3):499&#x2010;514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4836007</ArticleId><ArticleId IdType="pubmed">26727288</ArticleId></ArticleIdList></Reference><Reference><Citation>Lister JA, Lane BM, Nguyen A, Lunney K. Embryonic expression of zebrafish MiT family genes tfe3b, tfeb, and tfec. Dev Dyn. 2011;240(11):2529&#x2010;2538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3197887</ArticleId><ArticleId IdType="pubmed">21932325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapierre LR, De Magalhaes Filho CD, McQuary PR, et al. The TFEB orthologue HLH&#x2010;30 regulates autophagy and modulates longevity in Caenorhabditis elegans. Nat Commun. 2013;4:2267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3866206</ArticleId><ArticleId IdType="pubmed">23925298</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z, Ding R, Zhai X, et al. Common gene modules identified for chicken adiposity by network construction and comparison. Front Genet. 2020;11:537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272656</ArticleId><ArticleId IdType="pubmed">32547600</ArticleId></ArticleIdList></Reference><Reference><Citation>Steingrimsson E, Tessarollo L, Reid SW, Jenkins NA, Copeland NG. The bHLH&#x2010;zip transcription factor Tfeb is essential for placental vascularization. Development. 1998;125(23):4607&#x2010;4616.</Citation><ArticleIdList><ArticleId IdType="pubmed">9806910</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuiper RP, Schepens M, Thijssen J, et al. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)&#x2010;positive renal cell carcinomas due to promoter substitution. Hum Mol Genet. 2003;12(14):1661&#x2010;1669.</Citation><ArticleIdList><ArticleId IdType="pubmed">12837690</ArticleId></ArticleIdList></Reference><Reference><Citation>Steingrimsson E, Copeland NG, Jenkins NA. Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet. 2004;38:365&#x2010;411.</Citation><ArticleIdList><ArticleId IdType="pubmed">15568981</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher DE, Carr CS, Parent LA, Sharp PA. TFEB has DNA&#x2010;binding and oligomerization properties of a unique helix&#x2010;loop&#x2010;helix/leucine&#x2010;zipper family. Genes Dev. 1991;5(12a):2342.</Citation><ArticleIdList><ArticleId IdType="pubmed">1748288</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr CS, Sharp PA. A helix&#x2010;loop&#x2010;helix protein related to the immunoglobulin E box&#x2010;binding proteins. Mol Cell Biol. 1990;10(8):4384&#x2010;4388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC360994</ArticleId><ArticleId IdType="pubmed">2115126</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballabio A. The awesome lysosome. EMBO Mol Med. 2016;8(2):73&#x2010;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4734841</ArticleId><ArticleId IdType="pubmed">26787653</ArticleId></ArticleIdList></Reference><Reference><Citation>Settembre C, Fraldi A, Medina DL, Ballabio A. Signals from the lysosome: a control Centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol. 2013;14(5):283&#x2010;296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4387238</ArticleId><ArticleId IdType="pubmed">23609508</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardiello M, Palmieri M, di Ronza A, et al. A gene network regulating lysosomal biogenesis and function. Science. 2009;325(5939):473&#x2010;477.</Citation><ArticleIdList><ArticleId IdType="pubmed">19556463</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W, Wang F, Savini M, et al. TFEB regulates lysosomal proteostasis. Hum Mol Genet. 2013;22(10):1994&#x2010;2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">23393155</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri M, Impey S, Kang H, et al. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum Mol Genet. 2011;20(19):3852&#x2010;3866.</Citation><ArticleIdList><ArticleId IdType="pubmed">21752829</ArticleId></ArticleIdList></Reference><Reference><Citation>Nezich CL, Wang C, Fogel AI, Youle RJ. MiT/TFE transcription factors are activated during mitophagy downstream of parkin and Atg5. J Cell Biol. 2015;210(3):435&#x2010;450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4523611</ArticleId><ArticleId IdType="pubmed">26240184</ArticleId></ArticleIdList></Reference><Reference><Citation>Settembre C, De Cegli R, Mansueto G, et al. TFEB controls cellular lipid metabolism through a starvation&#x2010;induced autoregulatory loop. Nat Cell Biol. 2013;15(6):647&#x2010;658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3699877</ArticleId><ArticleId IdType="pubmed">23604321</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina DL, Fraldi A, Bouche V, et al. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell. 2011;21(3):421&#x2010;430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3173716</ArticleId><ArticleId IdType="pubmed">21889421</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardiello M. Transcription factor EB: from master coordinator of lysosomal pathways to candidate therapeutic target in degenerative storage diseases. Ann N Y Acad Sci. 2016;1371(1):3&#x2010;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5032832</ArticleId><ArticleId IdType="pubmed">27299292</ArticleId></ArticleIdList></Reference><Reference><Citation>Polito VA, Li H, Martini&#x2010;Stoica H, et al. Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO mol Med. 2014;6(9):1142&#x2010;1160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4197862</ArticleId><ArticleId IdType="pubmed">25069841</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Q, Yan P, Ma X, et al. Enhancing astrocytic lysosome biogenesis facilitates Abeta clearance and attenuates amyloid plaque pathogenesis. J Neurosci. 2014;34(29):9607&#x2010;9620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4099542</ArticleId><ArticleId IdType="pubmed">25031402</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JX, Malampati S, Zeng Y, et al. A small molecule transcription factor EB activator ameliorates beta&#x2010;amyloid precursor protein and tau pathology in Alzheimer's disease models. Aging Cell. 2020;19(2):e13069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6996953</ArticleId><ArticleId IdType="pubmed">31858697</ArticleId></ArticleIdList></Reference><Reference><Citation>Decressac M, Mattsson B, Weikop P, Lundblad M, Jakobsson J, Bjorklund A. TFEB&#x2010;mediated autophagy rescues midbrain dopamine neurons from alpha&#x2010;synuclein toxicity. Proc Natl Acad Sci USA. 2013;110(19):E1817&#x2010;E1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3651458</ArticleId><ArticleId IdType="pubmed">23610405</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehay B, Bove J, Rodriguez&#x2010;Muela N, et al. Pathogenic lysosomal depletion in Parkinson's disease. J Neurosci. 2010;30(37):12535&#x2010;12544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6633458</ArticleId><ArticleId IdType="pubmed">20844148</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang XX, Wang SF, Tan Y, et al. Pharmacological enhancement of TFEB&#x2010;mediated autophagy alleviated neuronal death in oxidative stress&#x2010;induced Parkinson's disease models. Cell Death Dis. 2020;11(2):128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7028954</ArticleId><ArticleId IdType="pubmed">32071296</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilpatrick K, Zeng Y, Hancock T, Segatori L. Genetic and chemical activation of TFEB mediates clearance of aggregated alpha&#x2010;synuclein. PLoS One. 2015;10(3):e0120819.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4366176</ArticleId><ArticleId IdType="pubmed">25790376</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsunemi T, Ashe TD, Morrison BE, et al. PGC&#x2010;1alpha rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci Transl Med. 2012;4(142):142ra197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096245</ArticleId><ArticleId IdType="pubmed">22786682</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada AR. PPARGC1A/PGC&#x2010;1alpha, TFEB and enhanced proteostasis in Huntington disease: defining regulatory linkages between energy production and protein&#x2010;organelle quality control. Autophagy. 2012;8(12):1845&#x2010;1847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3541300</ArticleId><ArticleId IdType="pubmed">22932698</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato Y, Kobayashi H, Higuchi T, Shimada Y, Ida H, Ohashi T. TFEB overexpression promotes glycogen clearance of Pompe disease iPSC&#x2010;derived skeletal muscle. Mol Ther Methods Clin Dev. 2016;3:16054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4980109</ArticleId><ArticleId IdType="pubmed">27556060</ArticleId></ArticleIdList></Reference><Reference><Citation>Seok S, Fu T, Choi SE, et al. Transcriptional regulation of autophagy by an FXR&#x2010;CREB axis. Nature. 2014;516(7529):108&#x2010;c104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4257899</ArticleId><ArticleId IdType="pubmed">25383523</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott I, Webster BR, Chan CK, Okonkwo JU, Han K, Sack MN. GCN5&#x2010;like protein 1 (GCN5L1) controls mitochondrial content through coordinated regulation of mitochondrial biogenesis and mitophagy. J Biol Chem. 2014;289(5):2864&#x2010;2872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3908418</ArticleId><ArticleId IdType="pubmed">24356961</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh A, Jana M, Modi K, et al. Activation of peroxisome proliferator&#x2010;activated receptor &#x3b1; induces lysosomal biogenesis in brain cells: implications for lysosomal storage disorders. J Biol Chem. 2015;290(16):10309&#x2010;10324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4400343</ArticleId><ArticleId IdType="pubmed">25750174</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Huang J, Gui T, et al. SR&#x2010;BI as a target of natural products and its significance in cancer. Semin Cancer Biol. 2020;80:18&#x2010;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">31935456</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao H, Yancey PG, Blakemore JL, et al. Macrophage SR&#x2010;BI modulates autophagy via VPS34 complex and PPARalpha transcription of Tfeb in atherosclerosis. J Clin Invest. 2021;131(7):e94229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8011903</ArticleId><ArticleId IdType="pubmed">33661763</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S, Fang Z, Luo W, et al. The C&#x2010;ETS2&#x2010;TFEB Axis promotes neuron survival under oxidative stress by regulating lysosome activity. Oxid Med Cell Longev. 2016;2016:4693703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4853961</ArticleId><ArticleId IdType="pubmed">27195074</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Tao Z, Zheng LD, et al. FoxO1 interacts with transcription factor EB and differentially regulates mitochondrial uncoupling proteins via autophagy in adipocytes. Cell Death Discovery. 2016;2:16066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5046220</ArticleId><ArticleId IdType="pubmed">27777789</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi TA, Majumder S, Thieme K, et al. Janus kinase 2 regulates transcription factor EB expression and autophagy completion in glomerular podocytes. J Am Soc Nephrol. 2017;28(9):2641&#x2010;2653.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576936</ArticleId><ArticleId IdType="pubmed">28424277</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W, Zhang CL, Gou L, et al. Endothelial TFEB (transcription factor EB) restrains IKK (IkappaB kinase)&#x2010;p65 pathway to attenuate vascular inflammation in diabetic db/db mice. Arterioscler Thromb Vasc Biol. 2019;39(4):719&#x2010;730.</Citation><ArticleIdList><ArticleId IdType="pubmed">30816805</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Qian Q, Li M, et al. The unfolded protein response regulates hepatic autophagy by sXBP1&#x2010;mediated activation of TFEB. Autophagy. 2021;17(8):1841&#x2010;1855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8386593</ArticleId><ArticleId IdType="pubmed">32597296</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JY, Sohn HY, Koh YH, Jo C. A splicing variant of TFEB negatively regulates the TFEB&#x2010;autophagy pathway. Sci Rep. 2021;11(1):21119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8548335</ArticleId><ArticleId IdType="pubmed">34702966</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Chen XC, Li ZH, et al. SMAD3 promotes autophagy dysregulation by triggering lysosome depletion in tubular epithelial cells in diabetic nephropathy. Autophagy. 2021;17(9):2325&#x2010;2344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8496726</ArticleId><ArticleId IdType="pubmed">33043774</ArticleId></ArticleIdList></Reference><Reference><Citation>Annunziata I, van de Vlekkert D, Wolf E, et al. MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat. Nat Commun. 2019;10(1):3623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6689058</ArticleId><ArticleId IdType="pubmed">31399583</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Cao C, Han DJ, et al. Dysregulation of miR&#x2010;342&#x2010;3p in plasma exosomes derived from convalescent AMI patients and its consequences on cardiac repair. Biomed Pharmacother. 2021;142:112056.</Citation><ArticleIdList><ArticleId IdType="pubmed">34435593</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiribuzi R, Crispoltoni L, Porcellati S, et al. miR128 up&#x2010;regulation correlates with impaired amyloid &#x3b2;(1&#x2010;42) degradation in monocytes from patients with sporadic Alzheimer's disease. Neurobiol Aging. 2013;9(4):P195.</Citation><ArticleIdList><ArticleId IdType="pubmed">24064186</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin HJR, Kim H, Oh S, et al. AMPK&#x2013;SKP2&#x2013;CARM1 signalling cascade in transcriptional regulation of autophagy. Nature. 2016;534(7608):553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5568428</ArticleId><ArticleId IdType="pubmed">27309807</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda S, Nah J, Shirakabe A, Zhai P, Sadoshima J. YAP plays a crucial role in the development of cardiomyopathy in lysosomal storage diseases. J Clin Invest. 2021;131(5):e143173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919732</ArticleId><ArticleId IdType="pubmed">33373332</ArticleId></ArticleIdList></Reference><Reference><Citation>Sancak Y, Bar&#x2010;Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. Ragulator&#x2010;rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell. 2010;141(2):290&#x2010;303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3024592</ArticleId><ArticleId IdType="pubmed">20381137</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoncu R, Bar&#x2010;Peled L, Efeyan A, Wang S, Sancak Y, Sabatini DM. mTORC1 senses lysosomal amino acids through an inside&#x2010;out mechanism that requires the vacuolar H+&#x2010;ATPase. Science. 2011;334(6056):678&#x2010;683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3211112</ArticleId><ArticleId IdType="pubmed">22053050</ArticleId></ArticleIdList></Reference><Reference><Citation>Martina JA, Puertollano R. Rag GTPases mediate amino acid&#x2013;dependent recruitment of TFEB and MITF to lysosomes. J Cell Biol. 2013;200(4):475&#x2010;491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3575543</ArticleId><ArticleId IdType="pubmed">23401004</ArticleId></ArticleIdList></Reference><Reference><Citation>Martina JA, Chen Y, Gucek M, Puertollano R. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy. 2012;8(6):903&#x2010;914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3427256</ArticleId><ArticleId IdType="pubmed">22576015</ArticleId></ArticleIdList></Reference><Reference><Citation>Roczniak&#x2010;Ferguson A, Petit CS, Froehlich F, et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal. 2012;5(228):ra42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3437338</ArticleId><ArticleId IdType="pubmed">22692423</ArticleId></ArticleIdList></Reference><Reference><Citation>Vega&#x2010;Rubin&#x2010;De&#x2010;Celis S, Pe&#xf1;A&#x2010;Llopis S, Konda M, Brugarolas J. Multistep regulation of TFEB by MTORC1. Autophagy. 2017;13(3):464&#x2010;472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5361595</ArticleId><ArticleId IdType="pubmed">28055300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferron M, Settembre C, Shimazu J, et al. A RANKL&#x2010;PKC&#x3b2;&#x2010;TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts. Genes Dev. 2013;27(8):955&#x2010;969.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3650231</ArticleId><ArticleId IdType="pubmed">23599343</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Xu M, Ding X, et al. Protein kinase C controls lysosome biogenesis independently of mTORC1. Nat Cell Biol. 2016;18(10):1065&#x2010;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">27617930</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Friedrichsen HJ, Andrews S, et al. A TFEB nuclear export signal integrates amino acid supply and glucose availability. Nat Commun. 2018;9(1):2685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6041281</ArticleId><ArticleId IdType="pubmed">29992949</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri M, Pal R, Nelvagal HR, et al. mTORC1&#x2010;independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nat Commun. 2017;8:14338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5303831</ArticleId><ArticleId IdType="pubmed">28165011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CL, Lee EX, Gordon KL, et al. MAP4K3 mediates amino acid&#x2010;dependent regulation of autophagy via phosphorylation of TFEB. Nat Commun. 2018;9(1):942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5838220</ArticleId><ArticleId IdType="pubmed">29507340</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Q, Jian Y, Xu M, et al. CDK4/6 regulate lysosome biogenesis through TFEB/TFE3. J Cell Biol. 2020;219(8):e201911036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7401801</ArticleId><ArticleId IdType="pubmed">32662822</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquette M, El&#x2010;Houjeiri L, C Zirden L, et al. AMPK&#x2010;dependent phosphorylation is required for transcriptional activation of TFEB and TFE3. Autophagy. 2021;17(12):3957&#x2010;3975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8726606</ArticleId><ArticleId IdType="pubmed">33734022</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras PS, Tapia PJ, Gonzalez&#x2010;Hodar L, et al. C&#x2010;Abl inhibition activates TFEB and promotes cellular clearance in a lysosomal disorder. iScience. 2020;23(11):101691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7607485</ArticleId><ArticleId IdType="pubmed">33163944</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina DL, Di Paola S, Peluso I, et al. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat Cell Biol. 2015;17(3):288&#x2010;299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4801004</ArticleId><ArticleId IdType="pubmed">25720963</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Cheng X, Yu L, et al. MCOLN1 is a ROS sensor in lysosomes that regulates autophagy. Nat Commun. 2016;7:12109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4931332</ArticleId><ArticleId IdType="pubmed">27357649</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabar NR, Heijjer CN, Shi CS, et al. LRRK2 is required for CD38&#x2010;mediated NAADP&#x2010;ca(2+) signaling and the downstream activation of TFEB (transcription factor EB) in immune cells. Autophagy. 2022;18(1):204&#x2010;222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8865229</ArticleId><ArticleId IdType="pubmed">34313548</ArticleId></ArticleIdList></Reference><Reference><Citation>Chae HJ, Kim HR, Xu C, et al. BI&#x2010;1 regulates an apoptosis pathway linked to endoplasmic reticulum stress. Mol Cell. 2004;15(3):355&#x2010;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">15304216</ArticleId></ArticleIdList></Reference><Reference><Citation>Bultynck G, Kiviluoto S, Henke N, et al. The C terminus of Bax inhibitor&#x2010;1 forms a Ca2+&#x2212;permeable channel pore. J Biol Chem. 2012;287(4):2544&#x2010;2557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3268414</ArticleId><ArticleId IdType="pubmed">22128171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HK, Lee GH, Bhattarai KR, et al. TMBIM6 (transmembrane BAX inhibitor motif containing 6) enhances autophagy through regulation of lysosomal calcium. Autophagy. 2021;17(3):761&#x2010;778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8032251</ArticleId><ArticleId IdType="pubmed">32167007</ArticleId></ArticleIdList></Reference><Reference><Citation>Martina JA, Puertollano R. Protein phosphatase 2A stimulates activation of TFEB and TFE3 transcription factors in response to oxidative stress. J Biol Chem. 2018;293(32):12525&#x2010;12534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6093222</ArticleId><ArticleId IdType="pubmed">29945972</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa J, Tokuda E, Yao Y, Sasaki T, Inoki K, Weisman LS. PP2A&#x2010;dependent TFEB activation is blocked by PIKfyve&#x2010;induced mTORC1 activity. Mol Biol Cell. 2022;33(3):ar26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9250387</ArticleId><ArticleId IdType="pubmed">35020443</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan CC, Dostie J, Diem MD, et al. eIF4A3 is a novel component of the exon junction complex. RNA. 2004;10(2):200&#x2010;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1370532</ArticleId><ArticleId IdType="pubmed">14730019</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakellariou D, Tiberti M, Kleiber TH, et al. eIF4A3 regulates the TFEB&#x2010;mediated transcriptional response via GSK3B to control autophagy. Cell Death Differ. 2021;28(12):3344&#x2010;3356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8630043</ArticleId><ArticleId IdType="pubmed">34158631</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakellariou D, Frankel LB. EIF4A3: a gatekeeper of autophagy. Autophagy. 2021;17(12):4504&#x2010;4505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8726629</ArticleId><ArticleId IdType="pubmed">34643458</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang TT, Back SH. Translation inhibitors activate autophagy master regulators TFEB and TFE3. Int J Mol Sci. 2021;22(21):12083.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8584619</ArticleId><ArticleId IdType="pubmed">34769510</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JX, Sun YR, Peluso I, et al. A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition. Autophagy. 2016;12(8):1372&#x2010;1389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968239</ArticleId><ArticleId IdType="pubmed">27172265</ArticleId></ArticleIdList></Reference><Reference><Citation>Magini A, Polchi A, Di Meo D, et al. Curcumin analogue C1 promotes hex and gal recruitment to the plasma membrane via mTORC1&#x2010;independent TFEB activation. Int J Mol Sci. 2019;20(6):1363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6471159</ArticleId><ArticleId IdType="pubmed">30889901</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Wang X, Li X, et al. Proteasome inhibition activates autophagy&#x2010;lysosome pathway associated with TFEB dephosphorylation and nuclear translocation. Front Cell Dev Biol. 2019;7:170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6713995</ArticleId><ArticleId IdType="pubmed">31508418</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Huang Y, Liu J, et al. Acetyltransferase GCN5 regulates autophagy and lysosome biogenesis by targeting TFEB. EMBO Rep. 2020;21(1):e48335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6945067</ArticleId><ArticleId IdType="pubmed">31750630</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Wang J, Zhou Z, et al. Importance of TFEB acetylation in control of its transcriptional activity and lysosomal function in response to histone deacetylase inhibitors. Autophagy. 2018;14(6):1043&#x2010;1059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6103407</ArticleId><ArticleId IdType="pubmed">30059277</ArticleId></ArticleIdList></Reference><Reference><Citation>Brijmohan AS, Batchu SN, Majumder S, et al. HDAC6 inhibition promotes transcription factor EB activation and is protective in experimental kidney disease. Front Pharmacol. 2018;9:34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5799228</ArticleId><ArticleId IdType="pubmed">29449811</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao J, Zheng L, Zhang Q, et al. Deacetylation of TFEB promotes fibrillar Abeta degradation by upregulating lysosomal biogenesis in microglia. Protein Cell. 2016;7(6):417&#x2010;433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4887328</ArticleId><ArticleId IdType="pubmed">27209302</ArticleId></ArticleIdList></Reference><Reference><Citation>Parashar NC, Parashar G, Nayyar H, Sandhir R. N(6)&#x2010;adenine DNA methylation demystified in eukaryotic genome: from biology to pathology. Biochimie. 2018;144:56&#x2010;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">29074394</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu Y, Zhao X, Wu YS, Li MM, Wang XJ, Yang YG. N6&#x2010;methyl&#x2010;adenosine (m6A) in RNA: an old modification with a novel epigenetic function. Genomics Proteomics Bioinformatics. 2013;11(1):8&#x2010;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4357660</ArticleId><ArticleId IdType="pubmed">23453015</ArticleId></ArticleIdList></Reference><Reference><Citation>Song H, Feng X, Zhang H, et al. METTL3 and ALKBH5 oppositely regulate m(6)a modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation&#x2010;treated cardiomyocytes. Autophagy. 2019;15(8):1419&#x2010;1437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6613905</ArticleId><ArticleId IdType="pubmed">30870073</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha Y, Rao L, Settembre C, Ballabio A, Eissa NT. STUB1 regulates TFEB&#x2010;induced autophagy&#x2010;lysosome pathway. EMBO J. 2017;36(17):2544&#x2010;2552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5579343</ArticleId><ArticleId IdType="pubmed">28754656</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AJ, Levy C, Davis IJ, Razin E, Fisher DE. Sumoylation of MITF and its related family members TFE3 and TFEB. J Biol Chem. 2005;280(1):146&#x2010;155.</Citation><ArticleIdList><ArticleId IdType="pubmed">15507434</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane CA, Hardy J, Schott JM. Alzheimer's disease. Eur J Neurol. 2018;25(1):59&#x2010;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">28872215</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci. 2011;34:185&#x2010;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3174086</ArticleId><ArticleId IdType="pubmed">21456963</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunan J, Small DH. Regulation of APP cleavage by alpha&#x2010;, beta&#x2010; and gamma&#x2010;secretases. FEBS Lett. 2000;483(1):6&#x2010;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">11033346</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Bromley&#x2010;Brits K, Song W. Regulation of beta&#x2010;site APP&#x2010;cleaving enzyme 1 gene expression and its role in Alzheimer's disease. J Neurochem. 2012;120(Suppl 1):62&#x2010;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">22122349</ArticleId></ArticleIdList></Reference><Reference><Citation>Grundke&#x2010;Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule&#x2010;associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA. 1986;83(13):4913&#x2010;4917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC323854</ArticleId><ArticleId IdType="pubmed">3088567</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickford F, Masliah E, Britschgi M, et al. The autophagy&#x2010;related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest. 2008;118(6):2190&#x2010;2199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2391284</ArticleId><ArticleId IdType="pubmed">18497889</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang DS, Stavrides P, Mohan PS, et al. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Brain. 2011;134(Pt 1):258&#x2010;277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3009842</ArticleId><ArticleId IdType="pubmed">21186265</ArticleId></ArticleIdList></Reference><Reference><Citation>Zare&#x2010;Shahabadi A, Masliah E, Johnson GV, Rezaei N. Autophagy in Alzheimer's disease. Rev Neurosci. 2015;26(4):385&#x2010;395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5039008</ArticleId><ArticleId IdType="pubmed">25870960</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Wang R, Xu S, Lakshmana MK. Transcription factor EB is selectively reduced in the nuclear fractions of Alzheimer's and amyotrophic lateral sclerosis brains. Neurosci J. 2016;2016:4732837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4940567</ArticleId><ArticleId IdType="pubmed">27433468</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy K, Cusack CL, Nnah IC, et al. Dysregulation of nutrient sensing and CLEARance in presenilin deficiency. Cell Rep. 2016;14(9):2166&#x2010;2179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4793148</ArticleId><ArticleId IdType="pubmed">26923592</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordi M, Berg MJ, Mohan PS, et al. Autophagy flux in CA1 neurons of Alzheimer hippocampus: increased induction overburdens failing lysosomes to propel neuritic dystrophy. Autophagy. 2016;12:2467&#x2010;2483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5173282</ArticleId><ArticleId IdType="pubmed">27813694</ArticleId></ArticleIdList></Reference><Reference><Citation>Xingzhi G, Peng T, Li C, et al. Amyloid &#x3b2;&#x2010;induced redistribution of transcriptional factor EB and lysosomal dysfunction in primary microglial cells. Front Aging Neurosci. 2017;9:228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5515861</ArticleId><ArticleId IdType="pubmed">28769785</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffey EE, Beckel JM, Laties AM, Mitchell CH. Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer's disease&#x2010;linked presenilin 1 A246E mutation can be reversed with cAMP. Neuroscience. 2014;263:111&#x2010;124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4028113</ArticleId><ArticleId IdType="pubmed">24418614</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Garbett K, Veeraraghavalu K, et al. A role for presenilins in autophagy revisited: normal acidification of lysosomes in cells lacking PSEN1 and PSEN2. J Neurosci. 2012;32(25):8633&#x2010;8648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3467018</ArticleId><ArticleId IdType="pubmed">22723704</ArticleId></ArticleIdList></Reference><Reference><Citation>Landel V, Baranger K, Virard I, et al. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease. Mol Neurodegener. 2014;9:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4237952</ArticleId><ArticleId IdType="pubmed">25213090</ArticleId></ArticleIdList></Reference><Reference><Citation>Parcon PA, Balasubramaniam M, Ayyadevara S, et al. Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs. Alzheimers Dement. 2018;14(2):230&#x2010;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6613789</ArticleId><ArticleId IdType="pubmed">28945989</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalia LV, Lang AE. Parkinson disease in 2015: evolving basic, pathological and clinical concepts in PD. Nat Rev Neurol. 2016;12(2):65&#x2010;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">26782330</ArticleId></ArticleIdList></Reference><Reference><Citation>Anglade P, Vyas S, Javoy&#x2010;Agid F, et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol. 1997;12(1):25&#x2010;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">9046040</ArticleId></ArticleIdList></Reference><Reference><Citation>Winslow AR, Chen CW, Corrochano S, et al. Alpha&#x2010;synuclein impairs macroautophagy: implications for Parkinson's disease. J Cell Biol. 2010;190(6):1023&#x2010;1037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3101586</ArticleId><ArticleId IdType="pubmed">20855506</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TN, Padman BS, Lazarou M. Deciphering the molecular signals of PINK1/parkin mitophagy. Trends Cell Biol. 2016;26(10):733&#x2010;744.</Citation><ArticleIdList><ArticleId IdType="pubmed">27291334</ArticleId></ArticleIdList></Reference><Reference><Citation>Valente EM, Abou&#x2010;Sleiman PM, Caputo V, et al. Hereditary early&#x2010;onset Parkinson's disease caused by mutations in PINK1. Science. 2004;304(5674):1158&#x2010;1160.</Citation><ArticleIdList><ArticleId IdType="pubmed">15087508</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392(6676):605&#x2010;608.</Citation><ArticleIdList><ArticleId IdType="pubmed">9560156</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickrell AM, Youle RJ. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron. 2015;85(2):257&#x2010;273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4764997</ArticleId><ArticleId IdType="pubmed">25611507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivankovic D, Chau KY, Schapira AH, Gegg ME. Mitochondrial and lysosomal biogenesis are activated following PINK1/parkin&#x2010;mediated mitophagy. J Neurochem. 2016;136(2):388&#x2010;402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4949652</ArticleId><ArticleId IdType="pubmed">26509433</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui A, Bhaumik D, Chinta SJ, et al. Mitochondrial quality control via the PGC1alpha&#x2010;TFEB signaling pathway is compromised by parkin Q311X mutation but independently restored by rapamycin. J Neurosci. 2015;35(37):12833&#x2010;12844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4571606</ArticleId><ArticleId IdType="pubmed">26377470</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker FO. Huntington's disease. Lancet. 2007;369(9557):218&#x2010;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">17240289</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez&#x2010;Vicente M, Talloczy Z, Wong E, et al. Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat Neurosci. 2010;13(5):567&#x2010;576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2860687</ArticleId><ArticleId IdType="pubmed">20383138</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Noh JY, Oh Y, et al. IRE1 plays an essential role in ER stress&#x2010;mediated aggregation of mutant huntingtin via the inhibition of autophagy flux. Hum Mol Genet. 2012;21(1):101&#x2010;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">21954231</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochaba J, Lukacsovich T, Csikos G, et al. Potential function for the huntingtin protein as a scaffold for selective autophagy. Proc Natl Acad Sci USA. 2014;111(47):16889&#x2010;16894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4250109</ArticleId><ArticleId IdType="pubmed">25385587</ArticleId></ArticleIdList></Reference><Reference><Citation>Rui YN, Xu Z, Patel B, et al. Huntingtin functions as a scaffold for selective macroautophagy. Nat Cell Biol. 2015;17(3):262&#x2010;275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4344873</ArticleId><ArticleId IdType="pubmed">25686248</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Steimle PA, Ren Y, et al. Dictyostelium huntingtin controls chemotaxis and cytokinesis through the regulation of myosin II phosphorylation. Mol Biol Cell. 2011;22(13):2270&#x2010;2281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128529</ArticleId><ArticleId IdType="pubmed">21562226</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X&#x2010;linked spinal and bulbar muscular atrophy. Nature. 1991;352(6330):77&#x2010;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes CJ, Miranda HC, Frankowski H, et al. Polyglutamine&#x2010;expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. Nat Neurosci. 2014;17(9):1180&#x2010;1189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4180729</ArticleId><ArticleId IdType="pubmed">25108912</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua JP, Reddy SL, Merry DE, et al. Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy. Hum Mol Genet. 2014;23(5):1376&#x2010;1386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3919011</ArticleId><ArticleId IdType="pubmed">24150846</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N, Pandey UB. Autophagy dysregulation in ALS: when protein aggregates get out of hand. Front Mol Neurosci. 2017;10:263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5572252</ArticleId><ArticleId IdType="pubmed">28878620</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M, van Blitterswijk MM, Vlam L, et al. VCP mutations in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2012;33(4):e837&#x2010;e813.</Citation><ArticleIdList><ArticleId IdType="pubmed">22078486</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S. Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2011;70(5):349&#x2010;359.</Citation><ArticleIdList><ArticleId IdType="pubmed">21487309</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M, Valentine JS. Aggregation of copper&#x2010;zinc superoxide dismutase in familial and sporadic ALS. Antioxid Redox Signal. 2009;11(7):1603&#x2010;1614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2842589</ArticleId><ArticleId IdType="pubmed">19271992</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Liu H, Guan Y, et al. The altered autophagy mediated by TFEB in animal and cell models of amyotrophic lateral sclerosis. Am J Transl Res. 2015;7(9):1574&#x2010;1587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4626419</ArticleId><ArticleId IdType="pubmed">26550457</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugolino J, Ji YJ, Conchina K, et al. Loss of C9orf72 enhances autophagic activity via deregulated mTOR and TFEB signaling. PLoS Genet. 2016;12(11):e1006443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5119725</ArticleId><ArticleId IdType="pubmed">27875531</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji YJ, Ugolino J, Zhang T, Lu J, Kim D, Wang J. C9orf72/ALFA&#x2010;1 controls TFEB/HLH&#x2010;30&#x2010;dependent metabolism through dynamic regulation of rag GTPases. PLoS Genet. 2020;16(4):e1008738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188304</ArticleId><ArticleId IdType="pubmed">32282804</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Q, Wang H, Hao Z, et al. TDP&#x2010;43 loss of function increases TFEB activity and blocks autophagosome&#x2010;lysosome fusion. EMBO J. 2016;35(2):121&#x2010;142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718457</ArticleId><ArticleId IdType="pubmed">26702100</ArticleId></ArticleIdList></Reference><Reference><Citation>Arhzaouy K, Papadopoulos C, Schulze N, Pittman SK, Meyer H, Weihl CC. VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle. Autophagy. 2019;15(6):1082&#x2010;1099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6526815</ArticleId><ArticleId IdType="pubmed">30654731</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies FM, Fleming A, Rubinsztein DC. Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci. 2015;16(6):345&#x2010;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">25991442</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Q, Yan P, Ma X, et al. Neuronal&#x2010;targeted TFEB accelerates lysosomal degradation of APP, reducing Abeta generation and amyloid plaque pathogenesis. J Neurosci. 2015;35(35):12137&#x2010;12151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4556784</ArticleId><ArticleId IdType="pubmed">26338325</ArticleId></ArticleIdList></Reference><Reference><Citation>Becot A, Pardossi&#x2010;Piquard R, Bourgeois A, et al. The transcription factor EB reduces the intraneuronal accumulation of the Beta&#x2010;secretase&#x2010;derived APP fragment C99 in cellular and mouse Alzheimer's disease models. Cell. 2020;9(5):1204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7291113</ArticleId><ArticleId IdType="pubmed">32408680</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YD, Zhao JJ. TFEB participates in the Abeta&#x2010;induced pathogenesis of Alzheimer's disease by regulating the autophagy&#x2010;lysosome pathway. DNA Cell Biol. 2015;34(11):661&#x2010;668.</Citation><ArticleIdList><ArticleId IdType="pubmed">26368054</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn PH, Wang H, Dislich B, et al. ADAM10 is the physiologically relevant, constitutive alpha&#x2010;secretase of the amyloid precursor protein in primary neurons. EMBO J. 2010;29(17):3020&#x2010;3032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2944055</ArticleId><ArticleId IdType="pubmed">20676056</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YY, Hehr CL, Atkinson&#x2010;Leadbeater K, Hocking JC, McFarlane S. Targeting of retinal axons requires the metalloproteinase ADAM10. J Neurosci. 2007;27(31):8448&#x2010;8456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6673056</ArticleId><ArticleId IdType="pubmed">17670992</ArticleId></ArticleIdList></Reference><Reference><Citation>Prox J, Bernreuther C, Altmeppen H, et al. Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions. J Neurosci. 2013;33(32):12915&#x2010;12928. 12928a.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6619719</ArticleId><ArticleId IdType="pubmed">23926248</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh J, Choi SH, Romano DM, et al. ADAM10 missense mutations potentiate beta&#x2010;amyloid accumulation by impairing prodomain chaperone function. Neuron. 2013;80(2):385&#x2010;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4105199</ArticleId><ArticleId IdType="pubmed">24055016</ArticleId></ArticleIdList></Reference><Reference><Citation>Epis R, Marcello E, Gardoni F, et al. Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease. Brain. 2010;133(11):3323&#x2010;3335.</Citation><ArticleIdList><ArticleId IdType="pubmed">20805102</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Muthu Karuppan MK, Nair M, Lakshmana MK. Autophagy&#x2010;dependent increased ADAM10 mature protein induced by TFEB overexpression is mediated through PPARalpha. Mol Neurobiol. 2021;58(5):2269&#x2010;2283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8026501</ArticleId><ArticleId IdType="pubmed">33417226</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini&#x2010;Stoica H, Cole AL, Swartzlander DB, et al. TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading. J Exp Med. 2018;215(9):2355&#x2010;2377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6122971</ArticleId><ArticleId IdType="pubmed">30108137</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Wang R, Carrera I, Xu S, Lakshmana MK. TFEB overexpression in the P301S model of tauopathy mitigates increased PHF1 levels and lipofuscin puncta and rescues memory deficits. eNeuro. 2016;3(2):ENEURO.0042&#x2010;16.2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4876487</ArticleId><ArticleId IdType="pubmed">27257626</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Du S, Marsh JA, et al. TFEB regulates lysosomal exocytosis of tau and its loss of function exacerbates tau pathology and spreading. Mol Psychiatry. 2021;26(10):5925&#x2010;5939.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7609570</ArticleId><ArticleId IdType="pubmed">32366951</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai SN, Singh P, Varshney R, et al. Promising drug targets and associated therapeutic interventions in Parkinson's disease. Neural Regen Res. 2021;16(9):1730&#x2010;1739.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8328771</ArticleId><ArticleId IdType="pubmed">33510062</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai SN, Singh P. Advancement in the modelling and therapeutics of Parkinson's disease. J Chem Neuroanat. 2020;104:101752.</Citation><ArticleIdList><ArticleId IdType="pubmed">31996329</ArticleId></ArticleIdList></Reference><Reference><Citation>Arotcarena ML, Bourdenx M, Dutheil N, et al. Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies. JCI Insight. 2019;4(16):e129719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6777809</ArticleId><ArticleId IdType="pubmed">31434803</ArticleId></ArticleIdList></Reference><Reference><Citation>Torra A, Parent A, Cuadros T, et al. Overexpression of TFEB drives a pleiotropic neurotrophic effect and prevents Parkinson's disease&#x2010;related neurodegeneration. Mol Ther. 2018;26(6):1552&#x2010;1567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5986717</ArticleId><ArticleId IdType="pubmed">29628303</ArticleId></ArticleIdList></Reference><Reference><Citation>Vodicka P, Chase K, Iuliano M, et al. Autophagy activation by transcription factor EB (TFEB) in striatum of HDQ175/Q7 mice. J Huntingtons Dis. 2016;5(3):249&#x2010;260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5088406</ArticleId><ArticleId IdType="pubmed">27689619</ArticleId></ArticleIdList></Reference><Reference><Citation>Brattas PL, Hersbach BA, Madsen S, Petri R, Jakobsson J, Pircs K. Impact of differential and time&#x2010;dependent autophagy activation on therapeutic efficacy in a model of Huntington disease. Autophagy. 2021;17(6):1316&#x2010;1329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8204969</ArticleId><ArticleId IdType="pubmed">32374203</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Xu H, Zhang C, Yang X, Cai W, Chen X. A prion&#x2010;like domain of TFEB mediates the co&#x2010;aggregation of TFEB and mHTT. Autophagy. 2022;1&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9851196</ArticleId><ArticleId IdType="pubmed">35635192</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med. 1991;57(1):1&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">2062949</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinojima N, Yokoyama T, Kondo Y, Kondo S. Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin&#x2010;induced autophagy. Autophagy. 2007;3(6):635&#x2010;637.</Citation><ArticleIdList><ArticleId IdType="pubmed">17786026</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, Kondo Y. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal&#x2010;regulated kinase signaling pathways. Mol Pharmacol. 2007;72(1):29&#x2010;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">17395690</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, Pan XY, Xu Y, et al. Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage. Autophagy. 2012;8(5):812&#x2010;825.</Citation><ArticleIdList><ArticleId IdType="pubmed">22622204</ArticleId></ArticleIdList></Reference><Reference><Citation>Song HC, Chen Y, Chen Y, et al. GSK&#x2010;3beta inhibition by curcumin mitigates amyloidogenesis via TFEB activation and anti&#x2010;oxidative activity in human neuroblastoma cells. Free Radic Res. 2020;54(11&#x2013;12):918&#x2010;930.</Citation><ArticleIdList><ArticleId IdType="pubmed">32623920</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Liu C, Zhang J, et al. A self&#x2010;assembled alpha&#x2010;synuclein Nanoscavenger for Parkinson's disease. ACS Nano. 2020;14(2):1533&#x2010;1549.</Citation><ArticleIdList><ArticleId IdType="pubmed">32027482</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Yang C, Liu J, et al. A curcumin derivative activates TFEB and protects against parkinsonian neurotoxicity in vitro. Int J Mol Sci. 2020;21(4):1515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7073207</ArticleId><ArticleId IdType="pubmed">32098449</ArticleId></ArticleIdList></Reference><Reference><Citation>Emanuele E. Can trehalose prevent neurodegeneration? Insights from experimental studies. Curr Drug Targets. 2014;15(5):551&#x2010;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">24568549</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseinpour&#x2010;Moghaddam K, Caraglia M, Sahebkar A. Autophagy induction by trehalose: molecular mechanisms and therapeutic impacts. J Cell Physiol. 2018;233(9):6524&#x2010;6543.</Citation><ArticleIdList><ArticleId IdType="pubmed">29663416</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P, Cortese K, Crippa V, et al. Trehalose induces autophagy via lysosomal&#x2010;mediated TFEB activation in models of motoneuron degeneration. Autophagy. 2019;15(4):631&#x2010;651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6526812</ArticleId><ArticleId IdType="pubmed">30335591</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Liu FT, Wang YX, et al. Autophagic modulation by Trehalose reduces accumulation of TDP&#x2010;43 in a cell model of amyotrophic lateral sclerosis via TFEB activation. Neurotox Res. 2018;34(1):109&#x2010;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">29383655</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong SJ, Stitham J, Evans TD, et al. Trehalose causes low&#x2010;grade lysosomal stress to activate TFEB and the autophagy&#x2010;lysosome biogenesis response. Autophagy. 2021;17(11):3740&#x2010;3752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8632292</ArticleId><ArticleId IdType="pubmed">33706671</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuller M, Meikle PJ, Hopwood JJ. Epidemiology of lysosomal storage diseases: an overview. In: Mehta A, Beck M, Sunder&#x2010;Plassmann G, eds. Fabry Disease: Perspectives from 5&#x2009;Years of FOS. Oxford PharmaGenesis Ltd.Click here to enter text.; 2006:9&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">21290699</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrbach M, Clarke JT. Treatment of lysosomal storage disorders: progress with enzyme replacement therapy. Drugs. 2007;67(18):2697&#x2010;2716.</Citation><ArticleIdList><ArticleId IdType="pubmed">18062719</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowska E, Jakobkiewicz&#x2010;Banecka J, Baranska S, et al. Genistein&#x2010;mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression&#x2010;targeted isoflavone therapy for mucopolysaccharidoses. Eur J Hum Genet. 2006;14(7):846&#x2010;852.</Citation><ArticleIdList><ArticleId IdType="pubmed">16670689</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskot M, Montefusco S, Jakobkiewicz&#x2010;Banecka J, et al. The phytoestrogen genistein modulates lysosomal metabolism and transcription factor EB (TFEB) activation. J Biol Chem. 2014;289(24):17054&#x2010;17069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4059147</ArticleId><ArticleId IdType="pubmed">24770416</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler MBL, Kidmose RT, Szomek M, et al. Structural insight into eukaryotic sterol transport through Niemann&#x2010;pick type C proteins. Cell. 2019;179(2):485&#x2010;497 e418.</Citation><ArticleIdList><ArticleId IdType="pubmed">31543266</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao G, Yao Y, Liu J, et al. Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1 &#x2212;/&#x2212; mouse brain. Am J Pathol. 2007;171(3):962&#x2010;975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1959498</ArticleId><ArticleId IdType="pubmed">17631520</ArticleId></ArticleIdList></Reference><Reference><Citation>Arguello G, Balboa E, Tapia PJ, et al. Genistein activates transcription factor EB and corrects Niemann&#x2010;pick C phenotype. Int J Mol Sci. 2021;22(8):4220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8073251</ArticleId><ArticleId IdType="pubmed">33921734</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordero JG, Garcia&#x2010;Escudero R, Avila J, Gargini R, Garcia&#x2010;Escudero V. Benefit of oleuropein aglycone for Alzheimer's disease by promoting autophagy. Oxid Med Cell Longev. 2018;2018:5010741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5838478</ArticleId><ArticleId IdType="pubmed">29675133</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigacci S, Miceli C, Nediani C, et al. Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: a mechanistic insight. Oncotarget. 2015;6(34):35344&#x2010;35357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4742109</ArticleId><ArticleId IdType="pubmed">26474288</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossi C, Rigacci S, Ambrosini S, et al. The polyphenol oleuropein aglycone protects TgCRND8 mice against ass plaque pathology. PloS One. 2013;8(8):e71702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3738517</ArticleId><ArticleId IdType="pubmed">23951225</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls MG, Lewis LK, Yandle TG, Lord G, McKinnon W, Hilton PJ. Ouabain, a circulating hormone secreted by the adrenals, is pivotal in cardiovascular disease. Fact or fantasy? J Hypertens. 2009;27(1):3&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19050442</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang XS, Xu ZW, Yi TL, et al. Ouabain suppresses the growth and migration abilities of glioma U87MG cells through inhibiting the Akt/mTOR signaling pathway and downregulating the expression of HIF1alpha. Mol Med Rep. 2018;17(4):5595&#x2010;5600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5865999</ArticleId><ArticleId IdType="pubmed">29436645</ArticleId></ArticleIdList></Reference><Reference><Citation>Song HL, Demirev AV, Kim NY, Kim DH, Yoon SY. Ouabain activates transcription factor EB and exerts neuroprotection in models of Alzheimer's disease. Mol Cell Neurosci. 2019;95:13&#x2010;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">30594669</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X, Luo Y, Liang T, et al. Gypenoside XVII enhances lysosome biogenesis and autophagy flux and accelerates autophagic clearance of amyloid&#x2010;beta through TFEB activation. J Alzheimers Dis. 2016;52(3):1135&#x2010;1150.</Citation><ArticleIdList><ArticleId IdType="pubmed">27060963</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra S, Roy A, Jana M, Pahan K. Cinnamic acid activates PPARalpha to stimulate lysosomal biogenesis and lower amyloid plaque pathology in an Alzheimer's disease mouse model. Neurobiol Dis. 2019;124:379&#x2010;395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6382282</ArticleId><ArticleId IdType="pubmed">30578827</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CM, Liu MY, Wang F, et al. Anti&#x2010;amnesic effect of pseudoginsenoside&#x2010;F11 in two mouse models of Alzheimer's disease. Pharmacol Biochem Behav. 2013;106:57&#x2010;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">23541491</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Yang J, Liu C, et al. Pseudoginsenoside&#x2010;F11 alleviates cognitive deficits and Alzheimer's disease&#x2010;type pathologies in SAMP8 mice. Pharmacol Res. 2019;139:512&#x2010;523.</Citation><ArticleIdList><ArticleId IdType="pubmed">30394318</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao XC, Xue X, Zhang HT, et al. Pseudoginsenoside&#x2010;F11 alleviates oligomeric beta&#x2010;amyloid&#x2010;induced endosome&#x2010;lysosome defects in microglia. Traffic. 2019;20(1):61&#x2010;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">30375163</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishige K, Schubert D, Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med. 2001;30(4):433&#x2010;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">11182299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Choi KJ, Cho SJ, et al. Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors. Sci Rep. 2016;6:24933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4844953</ArticleId><ArticleId IdType="pubmed">27112200</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohnai G, Adachi H, Katsuno M, et al. Paeoniflorin eliminates a mutant AR via NF&#x2010;YA&#x2010;dependent proteolysis in spinal and bulbar muscular atrophy. Hum Mol Genet. 2014;23(13):3552&#x2010;3565.</Citation><ArticleIdList><ArticleId IdType="pubmed">24549037</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L, Li X, Meng S, Ma T, Wan L, Xu S. Chlorogenic acid alleviates Abeta25&#x2010;35&#x2010;induced autophagy and cognitive impairment via the mTOR/TFEB signaling pathway. Drug des Devel Ther. 2020;14:1705&#x2010;1716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7221680</ArticleId><ArticleId IdType="pubmed">32440096</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng F, Chen M, Tan Y, et al. Protective effects of Otophylloside N on pentylenetetrazol&#x2010;induced neuronal injury in vitro and in vivo. Front Pharmacol. 2016;7:224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4959150</ArticleId><ArticleId IdType="pubmed">27504096</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Huang XB, Wan QL, et al. Otophylloside B protects against Abeta toxicity in Caenorhabditis elegans models of Alzheimer's disease. Nat Prod Bioprospect. 2017;7(2):207&#x2010;214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5397390</ArticleId><ArticleId IdType="pubmed">28194725</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Wan QL, Mu QZ, et al. The lifespan&#x2010;promoting effect of Otophylloside B in Caenorhabditis elegans. Nat Prod Bioprospect. 2015;5(4):177&#x2010;183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4567989</ArticleId><ArticleId IdType="pubmed">26112394</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyaswamy A, Krishnamoorthi SK, Zhang H, et al. Qingyangshen mitigates amyloid&#x2010;beta and tau aggregate defects involving PPARalpha&#x2010;TFEB activation in transgenic mice of Alzheimer's disease. Phytomedicine. 2021;91:153648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34332287</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Su C, Iyaswamy A, et al. Celastrol enhances transcription factor EB (TFEB)&#x2010;mediated autophagy and mitigates tau pathology: implications for Alzheimer's disease therapy. Acta Pharm Sin B. 2022;12(4):1707&#x2010;1722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9279716</ArticleId><ArticleId IdType="pubmed">35847498</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin D, Colombi M, Moroni C, Hall MN. Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov. 2011;10(11):868&#x2010;880.</Citation><ArticleIdList><ArticleId IdType="pubmed">22037041</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove J, Martinez&#x2010;Vicente M, Vila M. Fighting neurodegeneration with rapamycin: mechanistic insights. Nat Rev Neurosci. 2011;12(8):437&#x2010;452.</Citation><ArticleIdList><ArticleId IdType="pubmed">21772323</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A, Majumder S, Richardson A, Strong R, Oddo S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid&#x2010;beta, and tau: effects on cognitive impairments. J Biol Chem. 2010;285(17):13107&#x2010;13120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2857107</ArticleId><ArticleId IdType="pubmed">20178983</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozcelik S, Fraser G, Castets P, et al. Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice. PLoS One. 2013;8(5):e62459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3646815</ArticleId><ArticleId IdType="pubmed">23667480</ArticleId></ArticleIdList></Reference><Reference><Citation>Spilman P, Podlutskaya N, Hart MJ, et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid&#x2010;beta levels in a mouse model of Alzheimer's disease. PLoS One. 2010;5(4):e9979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2848616</ArticleId><ArticleId IdType="pubmed">20376313</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W, Wang F, Lotfi P, Sardiello M, Segatori L. 2&#x2010;hydroxypropyl&#x2010;beta&#x2010;cyclodextrin promotes transcription factor EB&#x2010;mediated activation of autophagy: implications for therapy. J Biol Chem. 2014;289(14):10211&#x2010;10222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3974990</ArticleId><ArticleId IdType="pubmed">24558044</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhal A, Krystofiak ES, Jerome WG, Song B. 2&#x2010;hydroxypropyl&#x2010;gamma&#x2010;cyclodextrin overcomes NPC1 deficiency by enhancing lysosome&#x2010;ER association and autophagy. Sci Rep. 2020;10(1):8663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250861</ArticleId><ArticleId IdType="pubmed">32457374</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y, Chen J, Wu X, et al. Role of c&#x2010;Abl&#x2010;GSK3beta signaling in MPP+&#x2010;induced autophagy&#x2010;lysosomal dysfunction. Toxicol Sci. 2018;165(1):232&#x2010;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">30165626</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao K, Chen J, Yu H, et al. Poly (ADP&#x2010;ribose) polymerase 1 inhibition prevents neurodegeneration and promotes alpha&#x2010;synuclein degradation via transcription factor EB&#x2010;dependent autophagy in mutant alpha&#x2010;synucleinA53T model of Parkinson's disease. Aging Cell. 2020;19(6):e13163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7294777</ArticleId><ArticleId IdType="pubmed">32475059</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Mao K, Yu H, et al. p38&#x2010;TFEB pathways promote microglia activation through inhibiting CMA&#x2010;mediated NLRP3 degradation in Parkinson's disease. J Neuroinflammation. 2021;18(1):295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8686293</ArticleId><ArticleId IdType="pubmed">34930303</ArticleId></ArticleIdList></Reference><Reference><Citation>Dassati S, Schweigreiter R, Buechner S, Waldner A. Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease. Neuropharmacology. 2021;194:108378.</Citation><ArticleIdList><ArticleId IdType="pubmed">33160981</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Xu S, Wang N, et al. Dynasore suppresses mTORC1 activity and induces autophagy to regulate the clearance of protein aggregates in neurodegenerative diseases. Neurotox Res. 2019;36(1):108&#x2010;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">30924108</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra S, Roy A, Patel DR, Pahan K. PPARalpha between aspirin and plaque clearance. J Alzheimers Dis. 2019;71(2):389&#x2010;397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8163018</ArticleId><ArticleId IdType="pubmed">31424405</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra S, Jana M, Pahan K. Aspirin induces lysosomal biogenesis and attenuates amyloid plaque pathology in a mouse model of Alzheimer's disease via PPARalpha. J Neurosci. 2018;38(30):6682&#x2010;6699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6067079</ArticleId><ArticleId IdType="pubmed">29967008</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Wang H, Ying Z, Gao Q. Ibudilast enhances the clearance of SOD1 and TDP&#x2010;43 aggregates through TFEB&#x2010;mediated autophagy and lysosomal biogenesis: the new molecular mechanism of ibudilast and its implication for neuroprotective therapy. Biochem Biophys Res Commun. 2020;526(1):231&#x2010;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">32204915</ArticleId></ArticleIdList></Reference><Reference><Citation>Song N, Wang W, Jia F, et al. Assessments of plasma ghrelin levels in the early stages of parkinson's disease. Mov Disord. 2017;32(10):1487&#x2010;1491.</Citation><ArticleIdList><ArticleId IdType="pubmed">28681931</ArticleId></ArticleIdList></Reference><Reference><Citation>He X, Yuan W, Liu F, Feng J, Guo Y. Acylated ghrelin is protective against 6&#x2010;OHDA&#x2010;induced neurotoxicity by regulating autophagic flux. Front Pharmacol. 2020;11:586302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7872958</ArticleId><ArticleId IdType="pubmed">33584263</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito T, Inden M, Ueda T, Asaka Y, Kurita H, Hozumi I. The neuroprotective effects of activated alpha7 nicotinic acetylcholine receptor against mutant copper&#x2010;zinc superoxide dismutase 1&#x2010;mediated toxicity. Sci Rep. 2020;10(1):22157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7746719</ArticleId><ArticleId IdType="pubmed">33335227</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Xu D, Ho SL, Li HW, Yang R, Wong MS. A theranostic agent for in vivo near&#x2010;infrared imaging of beta&#x2010;amyloid species and inhibition of beta&#x2010;amyloid aggregation. Biomaterials. 2016;94:84&#x2010;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">27107167</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyaswamy A, Wang X, Krishnamoorthi S, et al. Theranostic F&#x2010;SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models. Redox Biol. 2022;51:102280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8921490</ArticleId><ArticleId IdType="pubmed">35286997</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Lin W, Jiang Y, et al. Electroacupuncture ameliorates beta&#x2010;amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB). Autophagy. 2021;17(11):3833&#x2010;3847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8632298</ArticleId><ArticleId IdType="pubmed">33622188</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai SN, Chaturvedi VK, Singh P, Singh BK, Singh MP. Mucuna pruriens in Parkinson's and in some other diseases: recent advancement and future prospective. 3 Biotech. 2020;10(12):522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7655893</ArticleId><ArticleId IdType="pubmed">33194526</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai SN, Yadav SK, Singh D, Singh SP. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP&#x2010;induced parkinsonian mouse model. J Chem Neuroanat. 2016;71:41&#x2010;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">26686287</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh SS, Rai SN, Birla H, et al. Effect of chlorogenic acid supplementation in MPTP&#x2010;intoxicated mouse. Front Pharmacol. 2018;9:757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6087758</ArticleId><ArticleId IdType="pubmed">30127737</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang DD. Mechanistic studies of the Nrf2&#x2010;Keap1 signaling pathway. Drug Metab Rev. 2006;38(4):769&#x2010;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">17145701</ArticleId></ArticleIdList></Reference><Reference><Citation>Mingione A, Pivari F, Plotegher N, et al. Inhibition of ceramide synthesis reduces alpha&#x2010;synuclein Proteinopathy in a cellular model of Parkinson's disease. Int J Mol Sci. 2021;22(12):6469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8234676</ArticleId><ArticleId IdType="pubmed">34208778</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau A, Wang XJ, Zhao F, et al. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol Cell Biol. 2010;30(13):3275&#x2010;3285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2897585</ArticleId><ArticleId IdType="pubmed">20421418</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JY, Kim S, Sohn HY, Koh YH, Jo C. TFEB activates Nrf2 by repressing its E3 ubiquitin ligase DCAF11 and promoting phosphorylation of p62. Sci Rep. 2019;9(1):14354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778067</ArticleId><ArticleId IdType="pubmed">31586112</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;169(2):361&#x2010;371.</Citation><ArticleIdList><ArticleId IdType="pubmed">28388417</ArticleId></ArticleIdList></Reference><Reference><Citation>Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K pathway in human disease. Cell. 2017;170(4):605&#x2010;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5726441</ArticleId><ArticleId IdType="pubmed">28802037</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarafdar A, Michie AM. Protein kinase C in cellular transformation: a valid target for therapy? Biochem Soc Trans. 2014;42(6):1556&#x2010;1562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4613511</ArticleId><ArticleId IdType="pubmed">25399570</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera RM, Stoykova S, Nicolay BN, et al. Transcriptional control of autophagy&#x2010;lysosome function drives pancreatic cancer metabolism. Nature. 2015;524(7565):361&#x2010;365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5086585</ArticleId><ArticleId IdType="pubmed">26168401</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>